NPI: 1881653244 · SACRAMENTO, CA 95823 · End-Stage Renal Disease (ESRD) Treatment Clinic/Center · NPI assigned 03/22/2006
Authorized official WEY, SAMUEL controls 20+ related entities in our dataset. Read more
| Authorized Official | WEY, SAMUEL (VP, LICENSURE & CERTIFICATION) |
| NPI Enumeration Date | 03/22/2006 |
Other providers sharing the same authorized official: WEY, SAMUEL
| Provider | City | State | Total Paid |
|---|---|---|---|
| DVA HEALTHCARE RENAL CARE INC | NORTH HOLLYWOOD | CA | $16.47M |
| DVA HEALTHCARE RENAL CARE INC | DELANO | CA | $16.43M |
| DVA RENAL HEALTHCARE INC | LOS ANGELES | CA | $15.51M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $14.93M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.67M |
| DVA RENAL HEALTHCARE INC | OAKLAND | CA | $13.42M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.25M |
| DVA HEALTHCARE RENAL CARE INC | YUMA | AZ | $12.88M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $12.77M |
| DVA RENAL HEALTHCARE INC | FULLERTON | CA | $12.19M |
| DVA HEALTHCARE RENAL CARE INC | POMONA | CA | $11.96M |
| DVA RENAL HEALTHCARE INC | ANAHEIM | CA | $11.32M |
| DVA RENAL HEALTHCARE INC | ESCONDIDO | CA | $10.94M |
| DVA HEALTHCARE RENAL CARE INC | COSTA MESA | CA | $10.08M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $9.46M |
| DVA RENAL HEALTHCARE INC | VISALIA | CA | $9.22M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $8.83M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $8.56M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $7.78M |
| DVA RENAL HEALTHCARE INC | PALM SPRINGS | CA | $7.48M |
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 20,725 | $1.78M |
| 2019 | 21,064 | $1.90M |
| 2020 | 21,683 | $1.20M |
| 2021 | 26,614 | $1.11M |
| 2022 | 26,048 | $1.07M |
| 2023 | 21,329 | $1.30M |
| 2024 | 17,479 | $1.41M |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 90999 | Unlisted dialysis procedure, inpatient or outpatient | 67,052 | 6,821 | $9.74M |
| A4657 | Syringe, with or without needle, each | 15,447 | 2,410 | $16K |
| J1270 | Injection, doxercalciferol, 1 mcg | 20,426 | 2,383 | $8K |
| J1756 | Injection, iron sucrose, 1 mg | 10,909 | 3,061 | $4K |
| G0008 | Administration of influenza virus vaccine | 200 | 195 | $877.29 |
| 90662 | 62 | 62 | $649.67 | |
| 90674 | 155 | 148 | $514.03 | |
| Q4081 | Injection, epoetin alfa, 100 units (for esrd on dialysis) | 26,347 | 2,366 | $461.22 |
| J0887 | Injection, epoetin beta, 1 microgram, (for esrd on dialysis) | 1,311 | 787 | $151.93 |
| 83970 | 531 | 491 | $66.11 | |
| 0250 | 7,929 | 513 | $40.29 | |
| 85041 | 727 | 648 | $4.82 | |
| 85048 | 710 | 631 | $4.07 | |
| 82728 | 322 | 300 | $0.00 | |
| 83550 | 307 | 289 | $0.00 | |
| 0821 | 99 | 90 | $0.00 | |
| 90940 | 97 | 88 | $0.00 | |
| G0499 | Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result | 49 | 40 | $0.00 |
| 83540 | 319 | 301 | $0.00 | |
| J1644 | Injection, heparin sodium, per 1000 units | 1,911 | 157 | $0.00 |
| 82108 | 32 | 31 | $0.00 |